| European Case Law Identifier: | ECLI:EP:BA:1999:T043196.19990223 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 23 February 1999 | ||||||||
| Case number: | T 0431/96 | ||||||||
| Application number: | 84102916.8 | ||||||||
| IPC class: | C12P 21/08 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | A method for the preparation of monoclonal antibody with specificity for crosslinked fibrin derivatives and an assay procedure using said antibody | ||||||||
| Applicant name: | Agen Biomedical Limited | ||||||||
| Opponent name: | Behringwerke Aktiengesellschaft Innogenetics NV |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request - sufficiency of disclosure (yes) Inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t960431eu1.html
Date retrieved: 17 May 2021